Structure, mechanism and inhibition of anthranilate phosphoribosyltransferase

被引:7
|
作者
Scully, Thomas W. W. [1 ,2 ]
Jiao, Wanting [1 ,2 ]
Mittelstaedt, Gerd [1 ,2 ]
Parker, Emily J. J. [1 ,2 ]
机构
[1] Victoria Univ Wellington, Ferrier Res Inst, Wellington 6140, New Zealand
[2] Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand
关键词
PRT; AnPRT; TrpD; tryptophan biosynthesis; TRANSITION-STATE STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; ADENINE PHOSPHORIBOSYLTRANSFERASE; TRYPTOPHAN BIOSYNTHESIS; SULFOLOBUS-SOLFATARICUS; SUBSTRATE; FORMS; METABOLISM;
D O I
10.1098/rstb.2022.0039
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Anthranilate phosphoribosyltransferase catalyses the second reaction in the biosynthesis of tryptophan from chorismate in microorganisms and plants. The enzyme is homodimeric with the active site located in the hinge region between two domains. A range of structures in complex with the substrates, substrate analogues and inhibitors have been determined, and these have provided insights into the catalytic mechanism of this enzyme. Substrate 5-phospho-d-ribose 1-diphosphate (PRPP) binds to the C-terminal domain and coordinates to Mg2+, in a site completed by two flexible loops. Binding of the second substrate anthranilate is more complex, featuring multiple binding sites along an anthranilate channel. This multi-modal binding is consistent with the substrate inhibition observed at high concentrations of anthranilate. A series of structures predict a dissociative mechanism for the reaction, similar to the reaction mechanisms elucidated for other phosphoribosyltransferases. As this enzyme is essential for some pathogens, efforts have been made to develop inhibitors for this enzyme. To date, the best inhibitors exploit the multiple binding sites for anthranilate.This article is part of the theme issue 'Reactivity and mechanism in chemical and synthetic biology'.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase
    Olesen, Uffe H.
    Petersen, Jakob G.
    Garten, Antje
    Kiess, Wieland
    Yoshino, Jun
    Imai, Shin-Ichiro
    Christensen, Mette K.
    Fristrup, Peter
    Thougaard, Annemette V.
    Bjorkling, Fredrik
    Jensen, Peter B.
    Nielsen, Soren J.
    Sehested, Maxwell
    BMC CANCER, 2010, 10
  • [42] Structure, Mechanism, and Substrate Profiles of the Trinuclear Metallophosphatases from the Amidohydrolase Superfamily
    Ghodge, Swapnil V.
    Raushel, Frank M.
    PHOSPHATASES, 2018, 607 : 187 - 216
  • [43] Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs
    Luginina, Aleksandra
    Gusach, Anastasiia
    Marin, Egor
    Mishin, Alexey
    Brouillette, Rebecca
    Popov, Petr
    Shiriaeva, Anna
    Besserer-Offroy, Elie
    Longpre, Jean-Michel
    Lyapina, Elizaveta
    Ishchenko, Andrii
    Patel, Nilkanth
    Polovinkin, Vitaly
    Safronova, Nadezhda
    Bogorodskiy, Andrey
    Edelweiss, Evelina
    Hu, Hao
    Weierstall, Uwe
    Liu, Wei
    Batyuk, Alexander
    Gordeliy, Valentin
    Han, Gye Won
    Sarret, Philippe
    Katritch, Vsevolod
    Borshchevskiy, Valentin
    Cherezov, Vadim
    SCIENCE ADVANCES, 2019, 5 (10)
  • [44] Nicotinamide Phosphoribosyltransferase Inhibitors, Design, Preparation, and Structure-Activity Relationship
    Christensen, Mette K.
    Erichsen, Kamille D.
    Olesen, Uffe H.
    Tjornelund, Jette
    Fristrup, Peter
    Thougaard, Annemette
    Nielsen, Soren Jensby
    Sehested, Maxwell
    Jensen, Peter B.
    Loza, Einars
    Kalvinsh, Ivars
    Garten, Antje
    Kiess, Wieland
    Bjorkling, Fredrik
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) : 9071 - 9088
  • [45] Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility
    Zak, Mark
    Liederer, Bianca M.
    Sampath, Deepak
    Yuen, Po-wai
    Bair, Kenneth W.
    Baumeister, Timm
    Buckmelter, Alexandre J.
    Clodfelter, Karl H.
    Cheng, Eric
    Crocker, Lisa
    Fu, Bang
    Han, Bingsong
    Li, Guangkun
    Ho, Yen-Ching
    Lin, Jian
    Liu, Xiongcai
    Ly, Justin
    O'Brien, Thomas
    Reynolds, Dominic J.
    Skelton, Nicholas
    Smith, Chase C.
    Tay, Suzanne
    Wang, Weiru
    Wang, Zhongguo
    Xiao, Yang
    Zhang, Lei
    Zhao, Guiling
    Zheng, Xiaozhang
    Dragovich, Peter S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (03) : 529 - 541
  • [46] Inhibition of human carboxylesterases by ginsenosides: structure-activity relationships and inhibitory mechanism
    Sun, Zhao-Hui
    Chen, Jing
    Song, Yun-Qing
    Dou, Tong-Yi
    Zou, Li-Wei
    Hao, Da-Cheng
    Liu, Hai-Bin
    Ge, Guang-Bo
    Yang, Ling
    CHINESE MEDICINE, 2019, 14 (01)
  • [47] Cerebral Ischemia Is Exacerbated by Extracellular Nicotinamide Phosphoribosyltransferase via a Non-Enzymatic Mechanism
    Zhao, Bing
    Zhang, Meng
    Han, Xue
    Zhang, Xia-Yan
    Xing, Qiong
    Dong, Xu
    Shi, Qiao-Juan
    Huang, Peng
    Lu, Yun-Bi
    Wei, Er-Qing
    Xia, Qiang
    Zhang, Wei-Ping
    Tang, Chun
    PLOS ONE, 2013, 8 (12):
  • [48] Alternative IMP binding in feedback inhibition of hypoxanthine-guanine phosphoribosyltransferase from Thermoanaerobacter tengcongensis
    Chen, Q
    Liang, YH
    Su, XD
    Gu, XC
    Zheng, XF
    Luo, M
    JOURNAL OF MOLECULAR BIOLOGY, 2005, 348 (05) : 1199 - 1210
  • [49] Inhibition of Hypoxanthine-Guanine Phosphoribosyltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics
    Keough, Dianne T.
    Hockova, Dana
    Holy, Antonin
    Naesens, Lieve M. J.
    Skinner-Adams, Tina S.
    de Jersey, John
    Guddat, Luke W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4391 - 4399
  • [50] Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen
    Palacios, Daniel S.
    Meredith, Erik
    Kawanami, Toshio
    Adams, Christopher
    Chen, Xin
    Darsigny, Veronique
    Geno, Erin
    Palermo, Mark
    Baird, Daniel
    Boynton, Geoffrey
    Busby, Scott A.
    George, Elizabeth L.
    Guy, Chantale
    Hewett, Jeffrey
    Tierney, Laryssa
    Thigale, Sachin
    Weihofen, Wilhelm
    Wang, Louis
    White, Nicole
    Yin, Ming
    Argikar, Upendra A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (03) : 365 - 370